相关实验视频
Updated: Jul 11, 2025

05:05
A Modified Precipitation Method to Isolate Urinary Exosomes
Published on: January 16, 2015
17.6K
尿路生物标志物与极低妊娠年龄新生儿中CKD之间的关联
Sangeeta R Hingorani1, Robert H Schmicker2, Brian Halloran3
1Divisions of Nephrology, Department of Pediatrics, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, Washington.
概括
在患有慢性病 (CKD) 的早产婴儿中,尿液中的α-氨酸-S-转移酶水平较高. 这些发现表明,尿液生物标志物可能有助于监测脏疾病高风险新生儿.
科学领域:
- 新生儿医学 新生儿医学
- 腎臟病學 (nephrology) 是一種醫學.
- 生物标志物发现发现
背景情况:
- 在妊娠28周之前出生的婴儿面临患慢性病 (CKD) 的风险更高.
- 尿路生物标志物为早期检测和对新生儿中CKD发展的机制性见解提供了潜在的潜力.
- 现有研究强调需要改进的方法来预测这一脆弱人群中CKD风险.
研究的目的:
- 调查特定的尿路生物标志物与低妊娠年龄 (GA) 新生儿估计膜过率 (eGFR) 降低的进展之间的关联.
- 评估尿路生物标志物对预测早产婴儿慢性病 (CKD) 的有用性.
主要方法:
- 一项涉及327名怀孕24-27周出生的新生儿的队列研究,其中的一个子组接受了探索性病例控制分析.
- 尿路生物标志物在月经后27,30和34周的年龄被测量.
- 使用线性混合模型和邦费罗尼-霍尔姆校正来分析2年后对GA进行校正的eGFR相关的生物标志物差异.
主要成果:
- 在对GA进行调整后,在患有CKD的新生儿中与没有CKD的新生儿相比,观察到尿液中高水平的α-氨酸-S-转移酶,白素和囊素C.
- 在邦费罗尼-霍尔姆校正后,尿中的白蛋白和囊素C水平没有保持统计学意义.
- 探索性病例对照分析显示,病例和对照之间的测量生物标志物没有显著差异.
结论:
- 尿中的α-氨酸-S-转移酶可以作为一种潜在的生物标志物,用于识别患有CKD风险的新生儿.
- 需要进一步的研究来验证这些发现,并确认尿路生物标志物在监测早产婴儿病方面的作用.
- 早期识别和监测早产婴儿的CKD风险对于及时干预至关重要.
关键词:
极端早产,尿路生物标志物,慢性病相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
101
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
101
Serum Studies: Renal Function Tests
9
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
9
Urine Studies I: Urinalysis
21
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
21
Chronic Kidney Disease III: Interprofessional Care
13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
Chronic Kidney Disease I: Introduction
17
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17
Chronic Kidney Disease II: Clinical Manifestations
11
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
11

